Purpose
|
A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions.
|
Characteristics
|
Tradename: MIDAMOR Source of Compound: synthetic Target: Plasminogen inhibitor Receptor: Plasminogen activator, Sodium/hydrogen exchanger Status: USP, INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C6H9Cl2N7O
|
Solubility
|
DMSO 50 mg/mL, Water 5 mg/mL
|